Skip to main content
. 2011 Jan 14;17(2):181–190. doi: 10.3748/wjg.v17.i2.181

Figure 4.

Figure 4

Fas ligand siRNA attenuated oxaliplatin-, LY294002-, or combination-induced cell apoptosis. A: Fas ligand (FasL) expression was inhibited by FasL siRNA in MKN45 and AGS cells; B: FasL silencing decreased oxaliplatin-, LY294002-, or combination-induced cell apoptosis. aP < 0.05 vs LY294002 treatment; bP < 0.01 vs oxaliplatin treatment; dP < 0.01 vs combination of oxaliplatin and LY294002.